ZURA
Zura Bio Ltd
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Zura Bio Ltd
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Suvretta Capital ManagementSuvretta | $55.7M | 12.95% | +4.15% | |
| 2 | VR AdviserVR Adviser | $38.0M | 8.83% | 0.00% | |
| 3 | MPM Oncology Impact ManagementMPM Oncology Impact | $26.4M | 6.14% | new | |
| 4 | Great Point PartnersGreat Point Partners | $24.9M | 5.78% | 0.00% | |
| 5 | JPMorgan ChaseJPMorgan Chase | $24.5M | 5.70% | −2.34% | |
| 6 | BraidwellBraidwell | $23.5M | 5.46% | −0.22% | |
| 7 | SirenSiren | $22.0M | 5.12% | 0.00% | |
| 8 | BlackRockBlackRockindex-like | $21.3M | 4.96% | +690.34% | |
| 9 | Commodore CapitalCommodore Capital | $19.2M | 4.46% | 0.00% | |
| 10 | Adage Capital Partners GPAdage Capital Partners GP | $16.2M | 3.77% | 0.00% | |
| 11 | Saturn V Capital ManagementSaturn V | $12.4M | 2.88% | +183.95% | |
| 12 | QVT FinancialQVT Financial | $11.2M | 2.60% | +44.60% | |
| 13 | ADAR1 Capital ManagementADAR1 | $10.4M | 2.41% | +179.07% | |
| 14 | Armistice CapitalArmistice Capital | $9.7M | 2.24% | +8.56% | |
| 15 | Geode Capital ManagementGeodeindex-like | $9.3M | 2.17% | +200.22% | |
| 16 | Affinity Asset AdvisorsAffinity Asset | $8.6M | 2.01% | −42.90% | |
| 17 | StemPoint CapitalStemPoint Capital | $8.1M | 1.88% | +81.58% | |
| 18 | Ikarian CapitalIkarian Capital | $7.2M | 1.67% | +2.09% | |
| 19 | EcoR1 CapitalEcoR1 Capital | $7.0M | 1.62% | 0.00% | |
| 20 | Vestal Point CapitalVestal Point Capital | $6.9M | 1.61% | +129.74% | |
| 21 | State StreetState Streetindex-like | $5.9M | 1.37% | +413.76% | |
| 22 | Boxer Capital ManagementBoxer | $5.3M | 1.23% | 0.00% | |
| 23 | Vanguard Capital ManagementVanguardindex-like | $4.4M | 1.03% | +53.51% | |
| 24 | Goldman Sachs GroupGoldman Sachs | $3.4M | 0.79% | +275.34% | |
| 25 | PfizerPfizer | $3.2M | 0.74% | −81.02% |
No thesis.
Zura Bio Ltd
4.03
97 managers report $430.1M of Zura Bio on form 13F for the quarter ended Jun 30 '26. 18 of them hold 80% of it; Suvretta is largest at 12.95%.
Fund move
Fund move
No implied move.
No implied move.
Expected move
No implied move.
Linked news
News